Filing Details
HAEMONETICS CORP (NYSE:HAE) filed a Form 8-K with the Securities and Exchange Commission on August 18, 2026, disclosing a material event.
HAEMONETICS CORP (NYSE:HAE) filed a Form 8-K with the Securities and Exchange Commission on August 18, 2026, disclosing a material event.

At publication ·
HAEMONETICS CORP (NYSE:HAE) · 8k filed
At a glance
HAEMONETICS CORP (NYSE:HAE) filed a Form 8-K with the Securities and Exchange Commission on August 18, 2026, disclosing a material event.
HAEMONETICS CORP's stock currently trades at $104.65 with a market capitalization of $4.1B. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for HAEMONETICS CORP's stock.
All SEC filings for HAEMONETICS CORP are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View HAE Stock Page
Browse all filings on our HAE SEC filings page.
Public companies like HAEMONETICS CORP file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.
Current market data
NYSE · HAE
$101.06
Down: -$2.10 · -2.04%
Live quote updated
Keep reading